Cresco Labs Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 3/6

Cresco Labs şirketinin toplam hissedar öz sermayesi $365.4M ve toplam borcu $424.9M olup, bu da borç-öz sermaye oranını 116.3% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla $1.4B ve $1.0B dir. Cresco Labs 'in FAVÖK'ü $117.3M faiz karşılama oranı 2.1 dur. Şirketin $153.3M tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

116.3%

Borç/özkaynak oranı

US$424.86m

Borç

Faiz karşılama oranı	2.1x
Nakit	US$153.30m
Eşitlik	US$365.37m
Toplam yükümlülükler	US$1.02b
Toplam varlıklar	US$1.38b

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: CRLB.F 'nin kısa vadeli varlıkları ( $311.9M ) kısa vadeli yükümlülüklerini ( $158.6M ) aşıyor.

Uzun Vadeli Yükümlülükler: CRLB.F 'un kısa vadeli varlıkları ( $311.9M ) uzun vadeli yükümlülüklerini ( $859.0M ) karşılamamaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: CRLB.F 'nin net borç/öz sermaye oranı ( 74.3% ) yüksek olarak değerlendiriliyor.

Borcun Azaltılması: CRLB.F şirketinin borç/öz sermaye oranı son 5 yılda 0% seviyesinden 116.3% seviyesine yükseldi.

Bilanço

Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: Kârsız olan CRLB.F mevcut pozitif serbest nakit akışı seviyesini koruduğu takdirde 3 yıldan fazla yetecek nakit pistine sahip olacaktır.

Tahmini Nakit Akışı: CRLB.F kârlı değildir ancak serbest nakit akışının pozitif olması ve yılda % 30.1 oranında büyümesi nedeniyle 3 yıldan fazla bir süre yetecek nakit akışına sahiptir.

Cresco Labs Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 3/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

Cresco Labs Inc. to Report Q3, 2024 Results on Nov 08, 2024

Cresco Labs Inc. Announces Resignation of Tarik Brooks as Board of Directors

Cresco Labs Inc. Announces CFO Changes

Cresco Labs Inc. to Report Q2, 2024 Results on Aug 08, 2024

Cresco Labs Inc. (CNSX:CL) acquired Two medical dispensaries in Pennsylvania of Keystone Integrated Care, LLC for $9.8 million.

Cresco Labs Inc. to Report Q1, 2024 Results on May 15, 2024

Cresco Labs Inc., Annual General Meeting, Jun 10, 2024

Cresco Labs Inc. to Report Q4, 2023 Results on Mar 13, 2024

Cresco Labs Inc. Promotes Greg Butler to the Position of President

Cresco Labs Inc. to Report Q3, 2023 Results on Nov 15, 2023

Cresco Labs Inc. completed the acquisition of Sole Licensed Arizona Operation of Cresco Labs Inc.

Cresco Labs Inc. Provides Revenue Guidance for the Second Half of 2023

Cresco Labs Inc. to Report Q2, 2023 Results on Aug 16, 2023

Cresco Labs Inc. to Report Q1, 2023 Results on May 24, 2023

Combs Enterprises signed a definitive agreements to acquire Certain New York, Illinois, and Massachusetts assets of Cresco Labs Inc. and Columbia Care Inc. for approximately $190 million.

Cresco Labs Inc. to Report Q3, 2022 Results on Nov 15, 2022

Cresco Labs Inc. Announces Resignation of Sidney Dillard from the Board of Director

Aventine Property Group, Inc. acquired Cresco Labs Facility in Brookville, PA for $45 million

Cresco Labs Inc. to Report Q2, 2022 Results on Aug 17, 2022

Cresco Labs Inc. to Report Q1, 2022 Results on May 18, 2022

Cresco Labs Inc., Annual General Meeting, Jun 30, 2022

Cresco Labs Inc. Launches Floracal Farms Brand to Illinois

Cresco Labs Announces Launch of Khalifa Kush Products at Cookies Dispensaries Throughout California

Cresco Labs Inc. (CNSX:CL) completed the acquisition of Laurel Harvest Labs, LLC for $80 million.

Cresco Labs Inc. (CNSX:CL) completed the acquisition of Bay, LLC.

Cresco Labs Inc. (CNSX:CL) entered into a definitive agreement to acquire Bay, LLC for $90 million.

Cresco Labs Inc. (CNSX:CL) completed the acquisition of Cultivate Holdings, LLC.

Cresco Labs Inc. (CNSX:CL) entered into a definitive agreement to acquire Blair Wellness, LLC.

Cresco Labs Inc. Provides Earnings Guidance for the Year 2021

Cresco Labs Inc. (CNSX:CL) entered into a definitive agreement to acquire Cultivate Holdings, LLC for $158 million.

IM Cannabis Corp. (CNSX:IMCC) completed the acquisition of Trichome Financial Corp. (CNSX:TFC) from Cresco Labs Inc., Opaskawayak Cree Nation and others.

Cresco Labs Inc. to Report Q4, 2020 Results on Mar 25, 2021

Cresco Labs Inc. (CNSX:CL) acquired Four dispensaries of Verdant Creations.

Cresco Labs Signs Exclusive Distribution Agreement with California Cannabis Producer, Emerald Family Farms

Cresco Labs Appoints Ty Gent as the New Chief Operating Officer

Cresco Labs Expands High Supply Brand Portfolio to Include 1.0 g and 0.5 mg Live Cartridges Available in California and Illinois

Cresco Labs Inc. has completed a Follow-on Equity Offering in the amount of CAD 158.047776 million.

Cresco Labs Announces Executive Changes

Cresco Labs Inc. (CNSX:CL) entered into a definitive agreement to acquire all of the issued and outstanding shares of Bluma Wellness Inc. (CNSX:BWEL.U) for approximately $180 million.

Cresco Labs Debuts Deliciously DosedTM Chocolates from its Mindy's Chef Led Artisanal Edibles Brand for the Illinois Recreational Cannabis Market

Cresco Labs Launches Eighth Cannabis Brand, Wonder Wellness Co

Cresco Labs Launches 1.0 g Liquid Live Resin Vape Offering in Illinois and California

Cresco Labs Launches Remedi Cannabis Brand into New York

Cresco Labs Inc. to Report Q3, 2020 Results on Nov 18, 2020

Cresco Labs Bolsters Leadership Team with Three Senior Promotions

Innovative Industrial Properties, Inc. (NYSE:IIPR) completed the acquisition of two properties in Ohio and Michigan from Cresco Labs Inc. (CNSX:CL).

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Nakit Pist Analizi

Sağlıklı şirketleri keşfedin